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Assessing the importance of targeting the chronic Plasmodium falciparum malaria reservoir is pivotal as the world moves toward 
malaria eradication. Through the lens of a mathematical model, we show how, for a given malaria prevalence, the relative infectivity 
of chronic individuals determines what intervention tools are predicted be the most effective. Crucially, in a large part of the param-
eter space where elimination is theoretically possible, it can be achieved solely through improved case management. However, there 
are a significant number of settings where malaria elimination requires not only good vector control but also a mass drug adminis-
tration campaign. Quantifying the relative infectiousness of chronic malaria across a range of epidemiological settings would provide 
essential information for the design of effective malaria elimination strategies. Given the difficulties obtaining this information, we 
also provide a set of epidemiological metrics that can be used to guide policy in the absence of such data.
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In human feeding experiments, the measured infectivity of pat-
ent infections to mosquitoes seems to fluctuate significantly 
over time and not be linearly correlated with peripheral blood 
gametocyte counts [1]. In fact, several mosquito blood-feeding 
assays have shown that low gametocyte counts in humans do not 
preclude infection of mosquitoes, with a significant proportion 
of submicroscopic gametocytemias resulting in successful oocyst 
development in mosquitoes [2–6]. The data available suggest a 
sigmoidal relationship between human infectivity to mosquitoes 
and gametocyte density, with significant variation in infectivity 
levels at low gametocyte densities [7, 8]. Several estimates of the 
contribution of these submicroscopic gametocyte carriers to 
overall transmission reinforce that these infections are, in fact, 
nonnegligible [4, 5, 9, 10]. An analytical study that examined 
these infectivity trials has found that for low levels of transmis-
sion, submicroscopic infections could potentially be the source 
of 20%–50% of all human-to-mosquito transmissions [11]. 
Another study shows that gametocyte density can be larger in 
asymptomatic individuals than in some symptomatic patients 
[12]. That study also reported increased infectivity of asymptom-
atic gametocyte carriers not correlated with gametocyte densities, 
suggesting that other factors such as gametocyte maturity and/or 
human blood factors might influence their infectivity [13–15]. 
This might help explain why high gametocyte densities do not nec-
essarily result in mosquito infections [2, 6, 10]. One recent analysis 
of longitudinal data from Dielmo, Senegal, showed that gameto-
cyte densities increased as malaria prevalence decreased from 70% 
to 20% [16], further highlighting how factors determining the sex-
ual commitment of the malaria parasite can confound the assump-
tions of how asexual parasitemia translates into human infectivity 
to mosquitoes [17]. In summary, there is no consensus on the rela-
tive infectivity of chronic malaria infections compared with clinical 
infections, owing to sparseness of data, difficulties in measuring 
individuals’ infectivity over time, and the variable relationship 
between asexual parasitemia, gametocytemia, and infectivity.
EFFECT OF HETEROGENEOUS INFECTIVITY ON 
MALARIA TRANSMISSION
Accepting that clinical malaria infections are, on average, consid-
erably shorter in duration owing to treatment, and that chronic 
infections can extend up to several months, it is evident that, 
if clinical and chronic infections had similar infectivity, chronic 
infections would be the main contributors to overall malaria 
transmission. This has been explored theoretically in the past 
[18] and has helped in determining the limits for malaria control 
in low-transmission areas. That study presented a mathematical 
malaria transmission model that was used to fit age profiles of 
clinical malaria in 8 sub-Saharan Africa (SSA) regions of varying 
endemicity, to make inferences on key transmission parameters, 
such as region-specific entomological inoculation rates (EIRs), 
as well as setting independent parameters, such as the mean dur-
ation of clinical and chronic infections. 
This allowed the extrapolation of the relative infectiousness of 
chronic malaria infections, given specific relative infectivity 
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(ϕ) values. The estimated parameters suggested that chronic 
infections were 6 times longer in duration than clinical ones. 
Assuming ϕ to be 1, infectiousness would be 6 times higher 
in chronic infections. This means that in a clinically immune 
population, a single index case would generate 6 times more 
secondary infections than in a completely susceptible popula-
tion, because the majority of infections would be chronic in the 
former and clinical in the latter. This difference translates into a 
phenomenon termed bistability, characterized by the existence 
of 2 stable equilibria for a given parameter set.
Published estimates of infectiousness period length were 
derived from African data sets, with chronic infections thought to 
last about 150 days on average [18–20]. Although these estimates 
have accounted for differences in exposure across populations in 
Africa, they are not necessarily applicable to the Greater Mekong 
Subregion (GMS). Preliminary unpublished data exploring the 
duration of chronic carriage in a low-transmission setting in 
Vietnam suggest that infections in the GMS are slightly shorter 
in duration (approximately 100 days). This difference could be 
driven by disparities in parasite population structures. Parasite 
genetic diversity has been described as lower in Southeast Asia 
than in African settings with the same transmission intensity 
[21]. Although this fits with the suggested lower gene flow in 
Southeast Asia [22, 23], genetic factors are only a single deter-
minant among many that could account for differences in the 
period of infectiousness across malaria-endemic areas. 
Another well-documented significant difference between 
SSA and the GMS is their markedly distinct vector bionomics. 
Whereas the most abundant vectors in Africa are endophilic 
and antropophilic, in Southeast Asia vectors most commonly 
bite outdoors and do not preferentially bite humans [24–26]. 
This has major implications for the effectiveness of any vec-
tor-based control strategy, specifically insecticide-treated bed 
nets (ITNs) [27, 28] and indoor residual spraying (IRS).
In this article we use a previously developed theoretical frame-
work [18] to explore the predicted malaria prevalence at equilib-
rium across a range of relative infectivity values (ϕ) and vectorial 
capacities (VCs) (Figure  1). We do so for 2 distinct settings 
meant to characterize the generic features of malaria transmis-
sion in SSA and GMS settings. The 2 prototypical settings differ 
only in the assumed length of chronic infectiousness and vector 
control effectiveness, with SSA-like settings having an infec-
tiousness period of 165 days versus 100 days for GMS-like set-
tings. As mentioned above, vector control is much more “leaky” 
in the GMS, translating into an implemented 25% reduction in 
infection risk for the modeled vector control packages in the 
GMS, compared with an 80% reduction for the SSA simulations.
The model shows, as expected, that for a fixed value of ϕ 
malaria prevalence is predicted to increase as VC increases. Of 
more relevance, however, is that low levels of endemicity (ie, 
<30% prevalence) could occur as a result of a very large num-
ber of combinations of both VC and ϕ values. This means that 
a 20% malaria prevalence, for example, can result from a very 
large VC with the assumption that chronic infections are vir-
tually noninfectious, much lower VC with chronic infections 
being the main infection reservoir, or a range of intermediate 
scenarios. Details on all used model variables and key defini-
tions mentioned throughout the article can be found in Table 1.
USE OF OTHER EPIDEMIOLOGICAL METRICS TO 
DETERMINE THE CONTRIBUTION OF CHRONIC 
INFECTIONS TO MALARIA TRANSMISSION
The relative infectivity of chronic malaria infections remains 
largely unknown. There is a pressing need for high-quality data 
that can inform such a crucial driver of malaria transmission, 
which will require longitudinal follow-up studies in both clin-
ical and chronic infections, with serial mosquito-feeding assays. 
As we approach the elimination targets set by some GMS coun-
tries (as early as 2020), we need to make use of other more eas-
ily accessible data to advise national malaria control programs’ 
elimination strategies. Supplementary Figure S1 shows how 
different sets of VC and ϕ pairs lead to different predicted val-
ues for EIR, proportion of clinical malaria cases treated, all-age 
prevalence, percentage contribution of chronic infections to 
overall transmission, and the ratio of malaria prevalence in chil-
dren <10 years old to all-age malaria prevalence. These data (or 
at least some of them) are routinely collected and could circum-
vent the gap in our knowledge of what value ϕ should take. If we 
know the EIR, the proportion of clinical malaria cases treated, 
and the ratio of malaria prevalence in children <10 years old to 
all-age malaria prevalence in any specific setting, we can easily 
place that setting on our VC-ϕ coordinate system.
OPTIMAL CONTROL STRATEGIES FOR A GIVEN 
TRANSMISSION INTENSITY
The prospects for malaria control has been thoroughly explored 
analytically elsewhere [18], and its predictions have since been 
revisited [29]. In essence, assuming ϕ to be 1, there is a range 
of VC values for which stable elimination can be reached solely 
through the administration of effective antimalarial drugs to 
asymptomatic individuals, without the need for any additional 
vector control efforts. This is illustrated by the green-shaded 
areas in Figure  1. The dashed black line represents the elim-
ination threshold, that is, the malaria prevalence that must be 
achieved through treatment of both asymptomatic and sympto-
matic individuals. after which control measures can be relaxed 
and elimination is still achieved over time. If chronic infections 
are not transmissible ( φ = 0 ), however, treatment of asymp-
tomatic parasite carriers is completely ineffective, and vector 
control strategies (and potentially vaccination) emerge as the 
only means to halt transmission (left-most curves in Figure 1).
Figure 2 shows the timelines for elimination by deploying mass 
drug administration (MDA), vector control or MDA plus vector 
control strategies, assuming different combinations of VC and 
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ϕ for the 2 explored settings. These MDA elimination strategies 
consist of annual MDA campaigns of 3  monthly rounds each, 
whereas vector control strategies consist of integrated packages, 
including annual ITN distribution and IRS deployment cam-
paigns that reduce the VC by 80% in SSA-like settings and by 25% 
in GMS-like settings. It is clear that integrated control programs 
with both MDA and vector control components, are predicted to 
be by far the most efficient in reducing transmission to the point 
of elimination in a reasonable time frame for any parameter set. 
Although drug-centric approaches aimed at reducing the pool 
of chronic parasitemia can be the most effective strategy for a 
wide range of VC-ϕ combinations, for parameter combinations 
of high VC and low ϕ, the bistability region is lost, and elimin-
ation is rendered impossible with drug-centric approaches only. 
As expected, vector control–centric approaches have much less 
impact in GMS-like setting simulations and are predicted to be 
insufficient to eliminate malaria by themselves for high values 
of both VC and ϕ. Broadly, a few patterns emerge for potential 
operational programs considering different elimination horizons.
<5 Years
In SSA settings, control programs could choose either MDA or 
vector control for the lower end of EIRs to meet their elimin-
ation goal, because there is no combination of VC and ϕ values 
for which MDA outperforms vector control. For GMS-like set-
tings, stand-alone vector control approaches are viable only for 
very low EIRs, but vector control is still needed in combination 
with MDA to enable malaria elimination at high VC values.
≥5 Years 
Combined control strategies are only required for highest val-
ues of VC and ϕ in any setting. In GMS-like settings, MDA out-
performs vector control for combinations of low VC and high 
ϕ. Sustaining MDA campaigns for more than a couple of years 
Figure  1. Malaria equilibrium prevalence for different combinations of vectorial capacity (VC) and relative infectivity of chronic infections. Curves from left to right 
represent decreasing values of VC (18, 16, 14, 12, 10, 8, and 6 infectious bites per year) as indicated in the text boxes. Dashed lines reflect unstable equilibrium solutions 
(ie, elimination thresholds; solid lines, stable equilibrium solutions). The grey area illustrates the lower end of the malaria transmission spectrum which is usually deemed 
“controllable.” The green area delimits areas of unstable malaria transmission where malaria is expected to be eliminated over time without additional control measures. 
Abbreviations: GMS, Greater Mekong Subregion; SSA, sub-Saharan Africa.
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is not realistic owing to logistical considerations and concerns 
about the emergence or spread of drug resistance. We have 
thus focused on the potential impact of elimination strategies 
consisting of 2 annual MDA campaigns of 3 artemisinin com-
bination therapy (ACT) rounds each and vector control inter-
vention packages consisting of annual ITN and IRS campaigns 
(Figure 3). 
We chose parameters sets that illustrate the 3 possible out-
comes of elimination driven intervention strategies: successful 
elimination (lines 2 and 4) with the 2 annual MDA campaigns 
or 3  years of sustained vector control (note that elimination 
might only occur a few years after intervention has been halted); 
failure to eliminate where elimination is theoretically possible 
(lines 3 and 5) because the intervention effort was halted too 
soon, with resurgence following after a few years; and elimin-
ation impossible (lines 1 and 7), with malaria returning to base-
line prevalence levels soon after the intervention stops. 
One important factor to consider here is the speed at which 
MDA and vector control strategies reduce malaria prevalence. 
By definition, MDA campaigns consist of administering anti-
malarial drugs to as many individuals as possible, regardless of 
their infection status, producing a dramatic effect on malaria 
prevalence over a short period of time. If elimination is not 
achieved in the 12 months after MDA, then it is very unlikely 
to ever happen. Vector control, on the other hand, has a more 
diluted impact on transmission by affecting the likelihood that 
existing infections generate other infections. However, it has 
the advantage of being able to decrease the basic reproduction 
number (R0) past the R0 = 1 threshold, thus bringing the system 
to the bistability region for VC values >14 and potentially mak-
ing elimination viable for a wider spectrum of VC values.
By overlaying the epidemiological metrics displayed in 
Supplementary Figure S1 onto the elimination surfaces in 
Figure 2, we get very convenient measures of elimination feasi-
bility that can guide national malaria control programs in the 
absence of reliable data on the relative infectivity of chronic 
infections. These are shown as white lines in Figure 2 and help 
delimit the parameter space in which elimination can occur 
within a reasonable time frame (blue-colored surface).
For MDA approaches, elimination can be achieved with 2 
annual MDA campaigns if (1) baseline clinical case manage-
ment is very good, with 85% of all clinical cases getting treat-
ment; (2) EIR is <8; and (3) chronic infections are the main 
contributors to malaria transmission, with 85% of all infections 
originating in asymptomatically infected individuals. Strikingly, 
this is consistent in both SSA-like and GMS-like settings. For 
vector control approaches, elimination can be achieved with a 
3 year blanket intervention package of ITN and IRS if (1) base-
line clinical case management is very good, with 85% of all 
clinical cases getting treatment, and (2) children <10 years old 
Table 1. Key Definitions
Term Definition
VC Vectorial capacity (the average number of infectious bites arising from mosquitoes originally infected by a single infectious person per 
day), formally defined as follows:
VC =
-ma e gn
g
2
,
where m is the number of mosquitoes per person; a, daily mosquito biting rate; and n, duration of the mosquito sporogony cycle; and g, 
mosquito life expectancy in days
EIR Entomological inoculation rate (average number of infectious mosquito bites per person per year), formally defined as follows:
EIR VC= + -( ( )),cp c pf 1
where p is the proportion of infections that result in clinical malaria; and c, per-bite probability of infectious individuals with clinical mani-
festations to infect mosquitoes (commonly referred to as infectivity of humans to mosquitoes).
ϕ Relative infectivity of chronic compared with clinical infections
Infectiousness Overall transmissibility of 1 malaria infection over the course of the time when the infected person is infective to mosquitoes
R0 Basic reproduction number, formally defined as follows:
R
cp
Dc
c p
Da
0
1
= +
-é
ë
ê
ê
ù
û
ú
úVCb
f( )
,
where b is the per-bite probability that an infectious mosquito infects a susceptible human; Dc, mean duration of infectiousness for clin-
ical infections; and Da, mean duration of infectiousness in asymptomatic individuals
ContrA Contribution of chronic infections to overall malaria transmission; defined as follows:
( )
( )
1 1
1 1 1
- -
- + - -
p Da
pDc p Da
f
f
AgeR Ratio between malaria prevalence in children aged <10 y and all-age malaria prevalence
ITN Insecticide-treated bed net
IRS Indoor residual spraying
MDA Mass drug administration in the form of 3 rounds of artemisinin combination therapy treatment
Bistability Characterized by the existence of 2 stable equilibria for a given parameter set; the dynamics of the system converge to either the dis-
ease-free or the endemic equilibrium depending on the initial conditions (namely, initial prevalence); if the endemic state is perturbed 
past the unstable equilibrium solution (eg, through MDA), the system can converge to the disease-free equilibrium over time
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sustain ≤3.5% of all infections for SSA-like settings, or ≤2.6% 
for GMS-like settings. Of the tipping points presented here, the 
baseline clinical management coverage emerges as the most 
promising parameter for national control programs to adjust in 
order to increase their likelihood of success. 
Supplementary Figure S2 shows how elimination can become 
feasible for higher VC settings by increasing the baseline treat-
ment rates. It reflects the minimum treatment rate one would need 
to implement 1 year before an elimination strategy consisting of 
2 annual MDAs, for elimination to be achieved. This highlights 
how good malaria case management should be the foundation 
of any malaria control program. If we consider areas where case 
management rates are poor (<50% of cases receiving treatment), 
with little to no vector control, we can explore 3 hierarchical 
intervention strategies: (1) increasing case management rates to 
85%, (2) strategy 1 plus implementation of vector control pack-
ages decreasing VC by 80% in SSA and 25% in the GMS, and (3) 
strategy 2 plus deployment of 1 MDA campaign (3 ACT rounds).
Figure 2. Surfaces illustrating the minimum time required for elimination to be reached for a given combination of vectorial capacity and relative infectivity (ϕ). Colors 
reflect the time to elimination in years (the minimum time a given intervention must be sustained for elimination to be reached); this does not reflect the time it takes for 
malaria to be eliminated, because an intervention could be required to be sustained for only 1 year, and then relaxed, for example, with elimination following after another 
3 months. The contour lines indicate epidemiological metrics useful to determine the feasibility of control strategies in the simulated settings. Abbreviations: AgeR, ratio 
between malaria prevalence in children aged <10 y and all-age malaria prevalence; ContrA, contribution of chronic infections to overall malaria transmission; EIR, entomo-
logical inoculation rate; GMS, Greater Mekong Subregion; SSA, sub-Saharan Africa; Treat, proportion of clinical malaria cases treated.
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Model predictions indicate that improved case management 
alone (strategy 1) could lead to elimination in a significant range 
of VC-ϕ parameter combinations (Figure  4). In fact, elimin-
ation can be achieved without the need for any MDA campaign 
in about half the settings where malaria is deemed “control-
lable.” The lower efficiency imposed on simulated vector control 
strategies for the GMS is evidenced by how narrow region 2 in 
Figure 4 is, but also by the large gray area, depicting the param-
eter region where even strategy 3 is predicted to be insufficient 
to reach elimination. Novel vector control tools that circumvent 
efficiency gaps in currently existing tools could then potentially 
expand both areas 2 and 3 in the right panel in Figure 4.
DISCLAIMER
Here we provide a qualitative analysis of how the predicted 
success of elimination strategies in SSA or GMS settings is 
extremely sensitive to a biological parameters for which we have 
no rigorous estimate. We emphasize that the quantitative aspects 
of these simulations do not necessarily reflect what would be 
seen in the field due to region-specific factors, such as spatial 
transmission heterogeneity, individual infection risk heteroge-
neity, and intervention logistical constraints (none of which are 
taken into account here). The significant tradeoff between com-
plexity and tractability renders it impossible to analytically solve 
sophisticated models that take into account vector and human 
population dynamics with integrated within host dynamics. 
The simple model presented here has several limitations, mainly 
with respect to how it fails to capture heterogeneity. The main 
source of heterogeneity lacking in the simple model pertains 
to the transmission network describing the human-mosquito 
interface. Infection risk is known to be heterogeneous across 
individuals and is likely to be clustered (depending on mos-
quito habitat dispersal). These factors are well known to have 
an impact on dynamical systems’ behavior, but their impact on 
the likelihood and timeline of elimination is complex. The VC 
numbers presented throughout the article can be translated into 
Figure 3. Time dynamics of interventions for the combinations of vectorial capacity and relative infectivity highlighted 1–8 in Figure 2. The panels on the left illustrate 
2 MDA campaigns (3 rounds each) in consecutive years; those on the right, annual insecticide-treated bed net and indoor residual spraying campaigns over a period of 
3 years. Colors reflect those of the contour plots in Figure 2, indicating the predicted time to elimination. Abbreviations: GMS, Greater Mekong Subregion; MDA, mass drug 
administration; SSA, sub-Saharan Africa.
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a mean risk of infection (which is the same for each individual 
in the simple model explored here). 
If we consider a realistic scenario, wherein some individ-
uals are at greater risk and others can be at no risk, keeping 
the same mean risk of infection, we decrease the likelihood of 
reaching elimination, because transmission can be sustained 
by the individuals with a greater than mean risk of infection. 
Supplementary Figure S3 shows the results of a very sophisti-
cated individual-based model that assumes a skewed log-nor-
mal distribution of risk, wherein the majority of individuals are 
at little to no risk but some are constantly receiving infections, 
thus providing a more realistic but simultaneously “worst case” 
scenario. In this extreme example, the elimination parameter 
space is quite contracted, but the relative space attributable 
to each strategy is maintained. In this article, we intend not 
to make direct recommendations to national malaria control 
programs but rather to demonstrate how any rigorous rec-
ommendations considering detailed country-specific data are 
dependent on our assumptions about the duration of the infec-
tious period and the relative infectivity of chronic infections.
CONCLUSIONS
The relative infectivity of chronic infections has severe conse-
quences for malaria elimination prospects. Reliable estimates to 
inform that parameter will require longitudinal follow-up stud-
ies of sufficient duration in both clinical and chronic infections, 
with serial mosquito-feeding assays. Although we appreciate the 
time-consuming efforts involved and the significant logistical 
burden (specifically on the insectary) required to perform such 
a study, we consider those concerns to be greatly outweighed by 
the dramatic expected impact on malaria elimination policy. In 
the absence of such data, the presented model offers guidance 
as to what other more easily measurable epidemiological data 
might best inform elimination strategies’ likelihood of success. 
We also highlight how good case management should be the 
foundation of any malaria control strategy, having the potential 
to lead to elimination by itself in some settings.
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